CRSP - CRISPR chief medical officer resigns stepping down Jan. 26
2023-12-21 13:56:16 ET
More on CRISPR Therapeutics
- Vertex And CRISPR Therapeutics: Historic Exa-cel Approval, Why Market Is Nonplussed
- CRISPR Gene Editing: Intellia Vs. Crispr Therapeutics
- Crispr Therapeutics: The Party Is Over (Rating Downgrade)
- Vertex sickle cell disease drug clears major hurdle for EU approval
- TD Cowen cuts CRISPR to underperform, cites "irrational" valuation
For further details see:
CRISPR chief medical officer resigns, stepping down Jan. 26